Profs Urge 3rd Circ. To Rethink GSK Win In Wellbutrin Case

Fifty-eight law and business professors asked the Third Circuit on Thursday to reverse its approval of an infamous $233 million pay-for-delay settlement in which GlaxoSmithKline staved off the introduction of a...

Already a subscriber? Click here to view full article